Nathan Broudic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nathan Broudic has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Thierry Besson
Univ Rouen Normandie, INSA Rouen Normandie, Univ Caen Normandie, ENSICAEN, CNRS, Institut CARMeN UMR 6064, F-76130 Mont-Saint-Aignan, France
6 shared publications - Corinne Fruit
Univ Rouen Normandie, INSA Rouen Normandie, Univ Caen Normandie, ENSICAEN, CNRS, Institut CARMeN UMR 6064, F-76130 Mont-Saint-Aignan, France
5 shared publications Alexandra Pacheco-Benichou
Univ Rouen Normandie, France
2 shared publicationsA. A. Bondarenko
Univ Rouen Normandie, France
1 shared publication- Abdolali Alizadeh
Department of Chemistry Tarbiat Modares University P.O. Box 14115‐175 Tehran Iran
1 shared publication - Adepu Ramesh
Department of Civil Engineering, VNR Vignana Jyothi Institute of Engineering & Technology, Hyderabad, India
1 shared publication
Latest Publications
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Chimie du Sel d'Appel et des Acides Anthraniliques pour la synthèse de nouveaux hétérocycles.
Depuis plus de vingt ans, notre laboratoire cherche à synthétiser des structures hétérocycliques originales pour identifier de nouveaux inhibiteurs de la kinase DYRK1A, impliquée dans des maladies neurodégénératives. Les thiazolo[5,4-f]quinazolines et quinazolinones EHT1610 et FC162, découvertes au laboratoire, ont montré une capacité d’inhibition significative de l’activité de DYRK1A.. Cette thèse vise à développer une voie de synthèse des régioisomères linéaires de l’EHT1610 et du FC162 pour vérifier expérimentalement l'impact de la géométrie des dérivés de thiazoloquinazoline sur leurs activités biologiques. Une méthode de cyclisation pallado-catalysée des N-arylcyanothioformamides en 2-cyanobenzo[d]thiazoles a été mise au point et appliquée à divers réactifs pour synthétiser de nouveaux benzothiazoles polyfonctionnels linéaires. Ces composés ont ensuite été engagés dans une réaction inspirée de Niementowski et Bischler-Napieralski afin de créer une nouvelle chimiothèque de thiazolo-alcaloïdes originaux. Enfin, les analogues linéaires de l’EHT1610 et du FC162 ont été isolés pour la première fois. Leur évaluation biologique a montré que les géométries linéaires étaient inactives sur un panel de huit kinases, tandis que la structure thiazolo[5,4-g]quinazolinone s’est révélée cytotoxique à des concentrations micromolaires sur sept lignées cancéreuses. Une stratégie de modulation divergente a permis de synthétiser cinquante nouveaux composés. Le composé 261 s’est montré actif à des concentrations nanomolaires sur toutes les lignées cancéreuses par induction de la sénescence, sans affecter les cellules saines.
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Chimie du Sel d'Appel et des Acides Anthraniliques pour la synthèse de nouveaux hétérocycles.
Depuis plus de vingt ans, notre laboratoire cherche à synthétiser des structures hétérocycliques originales pour identifier de nouveaux inhibiteurs de la kinase DYRK1A, impliquée dans des maladies neurodégénératives. Les thiazolo[5,4-f]quinazolines et quinazolinones EHT1610 et FC162, découvertes au laboratoire, ont montré une capacité d’inhibition significative de l’activité de DYRK1A.. Cette thèse vise à développer une voie de synthèse des régioisomères linéaires de l’EHT1610 et du FC162 pour vérifier expérimentalement l'impact de la géométrie des dérivés de thiazoloquinazoline sur leurs activités biologiques. Une méthode de cyclisation pallado-catalysée des N-arylcyanothioformamides en 2-cyanobenzo[d]thiazoles a été mise au point et appliquée à divers réactifs pour synthétiser de nouveaux benzothiazoles polyfonctionnels linéaires. Ces composés ont ensuite été engagés dans une réaction inspirée de Niementowski et Bischler-Napieralski afin de créer une nouvelle chimiothèque de thiazolo-alcaloïdes originaux. Enfin, les analogues linéaires de l’EHT1610 et du FC162 ont été isolés pour la première fois. Leur évaluation biologique a montré que les géométries linéaires étaient inactives sur un panel de huit kinases, tandis que la structure thiazolo[5,4-g]quinazolinone s’est révélée cytotoxique à des concentrations micromolaires sur sept lignées cancéreuses. Une stratégie de modulation divergente a permis de synthétiser cinquante nouveaux composés. Le composé 261 s’est montré actif à des concentrations nanomolaires sur toutes les lignées cancéreuses par induction de la sénescence, sans affecter les cellules saines.
- Open Access
- 14 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (11) , 1733
Quinazoline-Derivatives of Imino-1,2,3-Dithiazoles Promote Biofilm Dispersion of Pseudomonas aeruginosa
Background/Objectives: Biofilm-associated infections pose a major clinical challenge since bacteria within biofilms exhibit highly antibiotic tolerance. Pseudomonas aeruginosa forms persistent biofilms that cause chronic infections in vulnerable patients, including those with cystic fibrosis, burns, or medical implants. Such biofilm-associated chronic infections require prolonged treatments that promote antimicrobial resistance. To address this, recent strategies focus on enhancing biofilm dispersion. Methods: Thirty-six N-arylimino-1,2,3-dithiazoles were screened for their biofilm dispersal activity using a crystal violet assay. Their cytotoxicity was assessed on A549 and HaCat eukaryotic cells. Moreover, their influence on bacterial growth and virulence was investigated. Lastly, fluorescence anisotropy was used to measure membrane fluidity to obtain the first insights on the mechanism of action of these chemicals. Results: Our results showed that quinazoline-derivatives of imino-1,2,3-dithiazoles display biofilm dispersion activity. These compounds do not increase virulence through pyocyanin production, do not modify the growth kinetics of P. aeruginosa, and do not show cytotoxicity towards eucaryotic cells. Conclusions: These findings highlight the potential use of N-arylimino-1,2,3-dithiazole-derived compounds as safe and effective dispersal agents of P. aeruginosa biofilms.
- 14 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (11) , 1733
Open AccessQuinazoline-Derivatives of Imino-1,2,3-Dithiazoles Promote Biofilm Dispersion of Pseudomonas aeruginosa
Background/Objectives: Biofilm-associated infections pose a major clinical challenge since bacteria within biofilms exhibit highly antibiotic tolerance. Pseudomonas aeruginosa forms persistent biofilms that cause chronic infections in vulnerable patients, including those with cystic fibrosis, burns, or medical implants. Such biofilm-associated chronic infections require prolonged treatments that promote antimicrobial resistance. To address this, recent strategies focus on enhancing biofilm dispersion. Methods: Thirty-six N-arylimino-1,2,3-dithiazoles were screened for their biofilm dispersal activity using a crystal violet assay. Their cytotoxicity was assessed on A549 and HaCat eukaryotic cells. Moreover, their influence on bacterial growth and virulence was investigated. Lastly, fluorescence anisotropy was used to measure membrane fluidity to obtain the first insights on the mechanism of action of these chemicals. Results: Our results showed that quinazoline-derivatives of imino-1,2,3-dithiazoles display biofilm dispersion activity. These compounds do not increase virulence through pyocyanin production, do not modify the growth kinetics of P. aeruginosa, and do not show cytotoxicity towards eucaryotic cells. Conclusions: These findings highlight the potential use of N-arylimino-1,2,3-dithiazole-derived compounds as safe and effective dispersal agents of P. aeruginosa biofilms.
- Open Access
- 30 October 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (11) , 1452
Novel Thiazole-Fused [4,5-g] or [5,4-g]Quinazolin-8-ones and Their Quinazoline Analogues: Synthesis and Biological Evaluation
Background/Objectives: In connection with previous work on V-shaped polycyclic thiazolo[5,4-f]quinazolin-9-one and [5,4-f]quinazoline derivatives that can modulate the activity of various kinases, the synthesis of straight thiazole-fused [4,5-g] or [5,4-g]quinazolin-8-ones and quinazoline derivatives hitherto undescribed was envisioned. Methods: An innovative protocol allowed to obtain the target structures. The synthesis of inverted thiazolo[4,5-h] and [5,4-h]quinazolin-8-one derivatives was also explored with the aim of comparing biological results. The compounds obtained were tested against a representative panel of eight mammalian protein kinases of human origin: CDK9/CyclinT, Haspin, Pim-1, GSK-3β, CK-1ε, JAK3, CLK1 and DYRK1A. Results and Conclusions: The results obtained show that the novel linear thiazoloquinazolines are not kinase inhibitors. The cytotoxicity of these newly synthesized compounds was assessed against seven representative tumor cell lines (human cancers: Huh7-D12, Caco-2, HCT-116, MCF-7, MDA-MB-231, MDA-MB-468 and PC-3). The majority of these novel molecules proved capable of inhibiting the growth of the tested cells. The 7-Benzyl-8-oxo-7,8-dihydrothiazolo[5,4-g]quinazolinones 5b and 6b are the most potent, with IC50 values in the micromolar range. None of these compounds showed toxicity against normal cells. A larger program of investigations will be launched to investigate the real potential interest of such compounds in anticancer applications.
- 30 October 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (11) , 1452
Open AccessNovel Thiazole-Fused [4,5-g] or [5,4-g]Quinazolin-8-ones and Their Quinazoline Analogues: Synthesis and Biological Evaluation
Background/Objectives: In connection with previous work on V-shaped polycyclic thiazolo[5,4-f]quinazolin-9-one and [5,4-f]quinazoline derivatives that can modulate the activity of various kinases, the synthesis of straight thiazole-fused [4,5-g] or [5,4-g]quinazolin-8-ones and quinazoline derivatives hitherto undescribed was envisioned. Methods: An innovative protocol allowed to obtain the target structures. The synthesis of inverted thiazolo[4,5-h] and [5,4-h]quinazolin-8-one derivatives was also explored with the aim of comparing biological results. The compounds obtained were tested against a representative panel of eight mammalian protein kinases of human origin: CDK9/CyclinT, Haspin, Pim-1, GSK-3β, CK-1ε, JAK3, CLK1 and DYRK1A. Results and Conclusions: The results obtained show that the novel linear thiazoloquinazolines are not kinase inhibitors. The cytotoxicity of these newly synthesized compounds was assessed against seven representative tumor cell lines (human cancers: Huh7-D12, Caco-2, HCT-116, MCF-7, MDA-MB-231, MDA-MB-468 and PC-3). The majority of these novel molecules proved capable of inhibiting the growth of the tested cells. The 7-Benzyl-8-oxo-7,8-dihydrothiazolo[5,4-g]quinazolinones 5b and 6b are the most potent, with IC50 values in the micromolar range. None of these compounds showed toxicity against normal cells. A larger program of investigations will be launched to investigate the real potential interest of such compounds in anticancer applications.
- 11 January 2024
- Published by Georg Thieme Verlag KG in Synthesis
- Vol. 56 (09) , 1485-1497
Synthesis of Thiazole-fused Tricyclic Quinazolinone Alkaloids and Their Derivatives
The synthesis of thiazole-fused derivatives of tricyclic quinazolinones hitherto undescribed was successfully achieved by replacing anthranilic acid or its derivatives by isomeric polyfunctionalized benzothiazole analogues of anthranilic methyl esters. Some of the new heterocyclic systems are inspired by natural alkaloids such as mackinazolinone, deoxyvasicinone, and isaindigotone, showing interesting biological properties. The microwave-assisted method developed is a variant of the Niementowski reaction and was also applied to the synthesis of ring-extended rutaecarpine derivatives.
- 11 January 2024
- Published by Georg Thieme Verlag KG in Synthesis
- Vol. 56 (09) , 1485-1497
Synthesis of Thiazole-fused Tricyclic Quinazolinone Alkaloids and Their Derivatives
The synthesis of thiazole-fused derivatives of tricyclic quinazolinones hitherto undescribed was successfully achieved by replacing anthranilic acid or its derivatives by isomeric polyfunctionalized benzothiazole analogues of anthranilic methyl esters. Some of the new heterocyclic systems are inspired by natural alkaloids such as mackinazolinone, deoxyvasicinone, and isaindigotone, showing interesting biological properties. The microwave-assisted method developed is a variant of the Niementowski reaction and was also applied to the synthesis of ring-extended rutaecarpine derivatives.
- Open Access
- 27 September 2023
- Published by Georg Thieme Verlag KG in Synthesis
- Vol. 55 (20)
Linked PDF of Table of Contents
Article published online: 27 September 2023 Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 27 September 2023
- Published by Georg Thieme Verlag KG in Synthesis
- Vol. 55 (20)
Open AccessLinked PDF of Table of Contents
Article published online: 27 September 2023 Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 4 May 2023
- Published by Georg Thieme Verlag KG in Synthesis
- Vol. 55 (20) , 3263-3271
Synthesis of Trifunctional Thiazole-Fused Anthranilonitrile and Anthranilic Acid Derivatives
The synthesis of trifunctional isomeric benzothiazoles derived from nitroanthranilic acids and their corresponding anthranilonitrile analogues is studied. Compared to previous work, the reaction sequence affords convenient access to hitherto undescribed 2-cyanobenzothiazoles. For further synthetic applications of these polyfunctional compounds, a hydrolysis–decarboxylation sequence is performed in an acidic medium (HCl or HBr), leading to an enlarged array of relevant building blocks.
- 4 May 2023
- Published by Georg Thieme Verlag KG in Synthesis
- Vol. 55 (20) , 3263-3271
Synthesis of Trifunctional Thiazole-Fused Anthranilonitrile and Anthranilic Acid Derivatives
The synthesis of trifunctional isomeric benzothiazoles derived from nitroanthranilic acids and their corresponding anthranilonitrile analogues is studied. Compared to previous work, the reaction sequence affords convenient access to hitherto undescribed 2-cyanobenzothiazoles. For further synthetic applications of these polyfunctional compounds, a hydrolysis–decarboxylation sequence is performed in an acidic medium (HCl or HBr), leading to an enlarged array of relevant building blocks.
- Open Access
Synthesis of 2-Cyanobenzothiazoles via Pd-Catalyzed/Cu-Assisted C-H Functionalization/Intramolecular C-S Bond Formation from N-Arylcyanothioformamides
We report herein on a catalytic system involving palladium and copper to achieve the cyclization of N-arylcyanothioformamides and the synthesis of 2-cyanobenzothiazoles. The C-H functionalization/intramolecular C-S bond formation reaction was achieved in the presence of air, using 2.0 equiv of an inorganic additive (KI). In many cases, the reaction led to a sole product regioselectively obtained in good yields, allowing the synthesis of a wide range of substituted 2-cyanobenzothiazole derivatives, providing valuable building blocks for the design of more complex heterocyclic or molecular labeling systems.
Open AccessSynthesis of 2-Cyanobenzothiazoles via Pd-Catalyzed/Cu-Assisted C-H Functionalization/Intramolecular C-S Bond Formation from N-Arylcyanothioformamides
We report herein on a catalytic system involving palladium and copper to achieve the cyclization of N-arylcyanothioformamides and the synthesis of 2-cyanobenzothiazoles. The C-H functionalization/intramolecular C-S bond formation reaction was achieved in the presence of air, using 2.0 equiv of an inorganic additive (KI). In many cases, the reaction led to a sole product regioselectively obtained in good yields, allowing the synthesis of a wide range of substituted 2-cyanobenzothiazole derivatives, providing valuable building blocks for the design of more complex heterocyclic or molecular labeling systems.